Mereo BioPharma Group Plc (MREO)
0.297
-0.01
(-3.91%)
USD |
NASDAQ |
Oct 16, 13:28
Mereo BioPharma Group SG&A Expense (TTM) : 19.44M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.44M |
| March 31, 2026 | 19.77M |
| December 31, 2025 | 23.06M |
| September 30, 2025 | 25.26M |
| June 30, 2025 | 25.52M |
| Date | Value |
|---|---|
| March 31, 2025 | 27.84M |
| December 31, 2024 | 26.44M |
| September 30, 2024 | 20.05M |
| June 30, 2024 | 13.78M |
| March 31, 2024 | 5.903M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biodexa Pharmaceuticals Plc | 5.629M |
| NuCana Plc | 7.064M |
| BioNTech SE | 833.57M |
| Silence Therapeutics Plc | 21.27M |
| Autolus Therapeutics Plc | 152.92M |